ArticleCardiology journal2026
Why atrial fibrillation ablation remains underused in EuroAsia Task Force countries: insights from the ESC-EHRA Atlas and a regional survey.
Article in Cardiology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of atrial fibrillation (AF) is increasing worldwide, yet access to catheter ablation remains uneven across regions. This study aimed to compare access to AF ablation across seven EuroAsia Task Force countries and identify barriers and potential strategies for improving service provision.
methodsThis cross-sectional study combined a secondary analysis of the 2025 European Society of Cardiology - European Heart Rhythm Association (ESC-EHRA) Atlas on Heart Rhythm Disorders with a structured regional survey. Procedural activity, infrastructure, and workforce indicators were compared with ESC reference medians and expressed per million population. Missing data for Turkmenistan were obtained from the national representative (2023). Exploratory correlations between ablation rates and healthcare expenditure indicators were assessed, including current health expenditure as a percentage of gross domestic product, out-of-pocket expenditure, domestic general government health expenditure, and current health expenditure per capita.
resultsAF ablation volume ranged from 2 to 190 procedures per million population, with six of seven countries below the European median (151 per million). Hospitals performing ablation ranged from 0.1 to 1.9 per million, with only one country exceeding the ESC median. No country met benchmarks for high-volume ablation centers or operator density. Fellowship density was low (0.1-1.3 per million). Financial barriers were identified as the main obstacle by five of six country representatives.
conclusionsAccess to AF ablation in EuroAsia Task Force countries is low and heterogeneous. Healthcare financing structure and per-capita health spending may be more important determinants of access than overall expenditure relative to gross domestic product.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.